Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma.
Jonasch E, Kumar UN, Linette GP, Hodi FS, Soiffer RJ, Ryan BF, Sober AJ, Mihm MC, Tsao H, Langley RG, Cosimi BA, Gadd MA, Tanabe KK, Souba W, Haynes HA, Barnhill R, Osteen R, Haluska FG.
Jonasch E, et al. Among authors: soiffer rj.
Cancer J. 2000 May-Jun;6(3):139-45.
Cancer J. 2000.
PMID: 10882328
Clinical Trial.